Shandong Pharmaceutical Glass Co Ltd (600529) — Cash Flow-to-Debt Ratio
Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of CN¥41.46 Million could theoretically repay 0% of its total liabilities (CN¥1.75 Billion) in one year. See 600529 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Pharmaceutical Glass Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see 600529 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Shandong Pharmaceutical Glass Co Ltd. Check Shandong Pharmaceutical Glass Co Ltd (600529) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥576.92 Million | CN¥1.75 Billion | ▼ -39.6% |
| 2024 | 0.55x | CN¥1.17 Billion | CN¥2.13 Billion | ▼ -7.0% |
| 2023 | 0.59x | CN¥1.05 Billion | CN¥1.78 Billion | ▲ +324.1% |
| 2022 | 0.14x | CN¥252.44 Million | CN¥1.82 Billion | ▼ -67.9% |
| 2021 | 0.43x | CN¥750.44 Million | CN¥1.74 Billion | ▲ +4.1% |
| 2020 | 0.41x | CN¥566.01 Million | CN¥1.37 Billion | ▼ -9.9% |
| 2019 | 0.46x | CN¥599.05 Million | CN¥1.30 Billion | ▲ +8.4% |
| 2018 | 0.42x | CN¥465.77 Million | CN¥1.10 Billion | ▼ -4.3% |
| 2017 | 0.44x | CN¥411.96 Million | CN¥929.84 Million | ▼ -24.7% |
| 2016 | 0.59x | CN¥506.53 Million | CN¥860.62 Million | ▲ +11.1% |
| 2015 | 0.53x | CN¥389.63 Million | CN¥735.61 Million | ▲ +37.6% |
| 2014 | 0.38x | CN¥266.63 Million | CN¥692.56 Million | ▼ -3.2% |
| 2013 | 0.40x | CN¥268.60 Million | CN¥675.48 Million | ▲ +836.7% |
| 2012 | 0.04x | CN¥28.52 Million | CN¥671.80 Million | ▼ -90.0% |
| 2011 | 0.43x | CN¥274.63 Million | CN¥644.80 Million | ▲ +52.8% |
| 2010 | 0.28x | CN¥217.01 Million | CN¥778.34 Million | ▼ -30.3% |
| 2009 | 0.40x | CN¥249.27 Million | CN¥623.51 Million | ▲ +132.9% |
| 2008 | 0.17x | CN¥91.76 Million | CN¥534.52 Million | ▼ -21.0% |
| 2007 | 0.22x | CN¥122.63 Million | CN¥564.66 Million | ▲ +95.4% |
| 2006 | 0.11x | CN¥78.47 Million | CN¥705.86 Million | ▲ +42.3% |
| 2005 | 0.08x | CN¥44.09 Million | CN¥564.27 Million | ▲ +1018.5% |
| 2004 | -0.01x | CN¥-3.70 Million | CN¥434.85 Million | ▼ -104.5% |
| 2003 | 0.19x | CN¥59.35 Million | CN¥310.80 Million | ▼ -48.7% |
| 2002 | 0.37x | CN¥109.26 Million | CN¥293.28 Million | ▲ +216.4% |
| 2001 | 0.12x | CN¥28.60 Million | CN¥242.90 Million | — |